# Nanopharm Limited – FDA Inspection, Sep 11, 2026

Source: https://www.keypedia.com/records/fda_inspections/nanopharm-limited/c0831ddb-57c9-4162-9919-7a006589b908
Source feed: FDA_Inspections

> FDA inspection 1340762 of Nanopharm Limited, September 11, 2026. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1340762
- Company Name: Nanopharm Limited
- Inspection Date: 2026-09-11
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1044784 - 2018-02-23
- [FDA Inspection 959767 - 2016-01-08](https://www.keypedia.com/records/fda_inspections/nanopharm-limited/eff99d96-a825-49cd-ae71-bd7c682e9a6f)
- FDA Inspection 803567 - 2012-10-16
- FDA Inspection 607685 - 2009-08-27

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kara-a-scheibner/63643a3f-4a8e-4dcc-8f1a-6fcf98519aad)

Company: https://www.keypedia.com/companies/nanopharm-limited/f4777b7f-47c3-4371-86cc-b7d21c936f6e

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8